Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/13/2019 |
| Start Date: | March 31, 2019 |
| End Date: | June 1, 2019 |
| Contact: | Clinical Trials Registry Team |
| Email: | IR-CTRegistration@Allergan.com |
| Phone: | 877-277-8566 |
XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
A retrospective, non-interventional, observational, multi-center, chart review study to be
conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone
procedure or in combination with phacoemulsification from 1 January 2014 to 1 October 2015.
conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone
procedure or in combination with phacoemulsification from 1 January 2014 to 1 October 2015.
Inclusion Criteria:
- Eye treated with XEN 45 Gel Stent for primary open angle glaucoma as a standalone
procedure or in combination with phacoemulsification
- XEN 45 Gel Stent was implanted between 1 January 2014 and 1 October 2015
Exclusion Criteria
We found this trial at
1
site
Click here to add this to my saved trials
